Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“Now, our fundraising focus turns to EMA Phase 3 studies, which we anticipate will cost approximately $9 million, of which about $900,000 is already raised. MAPS is seeking to raise these funds by the end of FY19.”
· Annual Financial Report Winter 2018 (MAPS Bulletin Vol. 28, No. 3) · own post

EMA Phase 3 fundraising target.

Descriptive, retrospective, or a statement of preference; no future state asserted.